21.03.2008 13:00:00

Medical Manufacturer TomoTherapy Implements SAP Solution in Only 16 Weeks

MADISON, Wis., March 21 /PRNewswire-FirstCall/ -- SAP America, Inc., a subsidiary of SAP AG , today announced that radiation therapy system manufacturer TomoTherapy Incorporated successfully implemented the SAP(R) Business All-in-One solution in a remarkable 16 weeks and realized immediate business benefits. In January 2007, TomoTherapy went live on SAP Business All-in-One with the goals of managing complex product innovation electronically and consolidating technological leadership in a high-growth market while exploring new international opportunities. SAP(R) Best Practices packages aided the implementation by anticipating the business needs of the radiation therapy system manufacturer, helping to reduce cost and reliance on external consultants.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050310/SFTH009LOGO-a)

"SAP Business All-in-One and SAP Best Practices gave TomoTherapy the tools to implement quickly, so that we could keep our focus on our customers," said Martin Christopher, director of IT, TomoTherapy. "Our system was delivered on time, within budget and with no unplanned downtime. With SAP Business All-in-One, TomoTherapy has much better visibility into our global operations and performance, and we enjoy the peace of mind that comes from having a fully compliant business system that enables us to comply with Sarbanes-Oxley. In addition, by taking advantage of the controls and integrated architecture of SAP Business All-in-One, we have more than doubled the throughput for engineering change orders, which directly benefits our customers."

Headquartered in Madison, Wisconsin, TomoTherapy reshapes radiation therapy with its unique TomoTherapy(R) Hi Art(R) treatment system, integrating CT imaging and helical intensity-modulated radiation therapy to improve the effectiveness and efficiency of radiation treatment for a wide range of cancer tumors. The medical manufacturer selected SAP for its technical excellence and long-term reliability to maintain the company's rapid pace of innovation and growth.

In recognition of the company's impressive technology consolidation, integration efforts and effective project management, TomoTherapy has been named "Regional Champion" representing the Americas in the recent SAP Best Practices success snapshot program. The company garnered the honor based on its rapid and innovative deployment project, which utilized pre-delivered blueprints, personalized system configuration, scenario and integration test scripts, end-user procedures, and other proprietary tools and templates.

The SAP Best Practices success snapshot program was created to highlight examples of the growing number of midmarket customers that are using SAP Best Practices embedded in SAP Business All-in-One to expedite solution implementation and improve operational excellence. In 2007, SAP and partner employees around the world submitted project profiles from 32 customers to the competition.

Copyright (C) 2008 SAP AG. All rights reserved. SAP, R/3, mySAP, mySAP.com, xApps, xApp, SAP NetWeaver and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries all over the world. All other product and service names mentioned are the trademarks of their respective companies. Data contained in this document serves informational purposes only. National product specifications may vary.

For customers interested in learning more about SAP products: Global Customer Center: +49 180 534-34-24

United States Only: 1 (800) 872-1SAP (1-800-872-1727) Contacts: Astrid Polchen, +49 (6227) 7-47644, astrid.poelchen@sap.com, CET Torrey Fazen, Burson-Marsteller, +1 (617) 406-1651, torrey.fazen@bm.com, EDT

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

DAX 19 425,73 0,85%
STOXX 50 4 294,93 0,47%
EURO STOXX 50 4 758,65 0,54%
EURO STOXX Technology 1 003,00 0,80%
Prime All Share 7 562,64 0,77%
HDAX 10 215,13 0,80%
CDAX 1 667,09 0,59%
NYSE International 100 7 535,50 0,03%
EURO STOXX 495,14 0,55%